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Summary: To investigate the role of the sympathetic System in Raynaud's phenomenon, which has not yet
been elucidated, we measured the levels of norepinephrine, epinephrine and dopamine before, immediately
and 30 min after the cold pressor test in plasma from 17 patients with primary, 6 with secondary RaynautTs
phenomenon and 19 volunteers, matched for age and sex. Patients had significantly low baseline epinephrine
(0.13 ± 0.02 vs 0.37 ± 0.04, nmol/1, p < 0.001, mean ± S. E.), but normal norepinephrine and dopamine
(norepinephrine: 1.77 ± 0.16 and 2.06 + 0.18; dopamine: 0.10 ± 0.01 and 0.11 + 0.02, patients and controls).
Immediately after the cold test norepinephrine significantly increased (p < 0.001) in patients (2.42 + 0.22)
and controls (3.24 ± 0.28); epinephrine increased in patients (0.18 ± 0.02, p < 0.02); dopamine did not show
any significant change (0.13 ± 0.01 and 0.13 ± 0.02, patients and controls).
In the recovery period, while norepinephrine and epinephrine returned to baseline in both groups, dopamine
increased in controls (0.21 + 0.04, p < 0.005) but remained unchanged in patients (0.11 ± 0.01).
We conclude that there is no sympathetic overactivity in Raynaud's phenomenon and propose a role for
circulating dopamine in post-ischaemic vasodilatation äs an explanation for the particular behaviour of
dopamine.
Introduction
primary Raynaud's phenomenon and 6 (5 women and l man,
The aetiopathögenesis of Raynaud's phenomenon is mean age 49 ± 3 years) secondary to systemic sclerosis. The
still uncertain: in particular, the role played by the äagnosis was based on accepted criteria (5, 6). The mean
t - . t · duration ofRaynaud*s Symptoms was 10 -l· 2 years. with a ränge
sympathetic System has not yet been clearly eluci-
 of 2 to 34 years A11 subj£cts were no™otensive and had no
dated. Data for and against the theory originally signs of cardiac involvement. The control group consisted of
proposed by Raynaud (1) of increased activity of the 19 healthy volunteers, matched for age and sex. None of the
- , i j- - j j / / ^ A\ subjects, inclüding controls, had taken any vasoactive drug
sympathetic System are almost evenly divided (2, 3,4).
 duriBg the previous ten days
Seeking clues to the role of the sympathetic System in Informed consent was obtained from all subjects.
the mechanism of Raynautfs phenomenon, we meas-
 After the subjects had sat for 15 min with an indwelling catheter
ured the levels of norepinephrine, epinephrine and inserted into the antecubital vein, baseline blood samples were
dopamine in response to the cold pressor test in taken for catecholamine assay. The cold pressor test was then
. ~ . . - j j performed by immersing the controlateral hand in ice water forplasma from patients with primary and secondary
 2 min Blood pressure and heart rate were recorded every 15 s
Raynaud's phenomenon. A second blood sample was taken immediately before removal
of the hand from the ice water. After a 30 min recovery period,
a third blood sample was taken. Plasma free catecholamines
Methods were measured by HPLC, with a coulometric detector äs pre-
viously described (7).
Twenty-three patients (20 women and 3 men, mean age ± S. E.
42 ± 3 years) with Raynaud's phenomenon were studied. Sev- The Student t test (a = 0.05) was used to compare unpaired
enteen (15 women and 2 men, mean age 40 ± 3 years) had data. Paired data were analysed using the two-way analysis of
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variance (ANOVA), considering diagnostic classes and experi-
mental phases äs classification factors. The phase and class
effects were further examined with the multiple paired t-test
with corrccted a level (0.0167).
Linear correlation cocfficients were also determined.
All data are expressed äs mean ± S. E.
Results
Because plasma free catecholamine concentration
seems to vary less in the seated subject (8),.our meas-
urements were made after the subjects had been sitting
for 15 min.
Resting epinephrine levels were significantly low in
patients (p < 0.001), while norepinephrine and do-
pamine concentrations, although towards lower limits
in patients, were similar in the two groups (tab. 1).
During the cold pressor test norepinephrine concen-
trations significantly increased (p < 0.001) in patients
(41%) and in controls (63%). Epinephrine concentra-
tions showed a significant increase in patients
(p < 0.02) but not in controls. However, absolute
values of the two amines remained significantly low
in patients. Dopamine levels slightly increased in pa-
tients. Thirty min after the cold pressor test, norepi-
nephrine and epinephrine returned to baseline in the
two groups. Dopamine rernainsd unchanged in pa-
tients, but significantly lower than in controls
(p < 0.05). In controls dopamine was found to be
increased, albeit with a wide ränge of variability.
No significant differences were found between pri-
mary and secondäry Raynaud's phenomenon in any
of the plasma catecholamine levels. There were no
correlations of any catecholamine levels with age or
sex in either group, or with the duration of the symp-
toms in patients.
Resting blood pressure and heart rate were similar in
the two groups, significantly increased in both groups
during the cold test (p < 0.001), and returned to base-
line in the recovery period in both groups (tab. 2).
There was no correlation between haeinodynainic pa-
rameters and catecholamine concentrations.
Tab. 1. Plasma norepinephrine, epinephrine and dopamine changes in 23 patients with Raynaud's phenomenon and 19 healthy
controls before, immediately and 30 min after the cold pressor test. Values are expressed äs nmol/l (mean ± S. E.).
Subjects
Norepinephrine
Patients
Controls
Epinephrine
Patients
Controls
Dopamine
Patients
Controls
n
23
19
23
19
23
19
Baseline
1.77 + 0.16
2.06 + 0.18
0.13 + 0.02
0.37 + 0.04
0.10 + 0.01
0.11 +0.02
Cold test
2.42 + 0.22
3.24 + 0.28
0.18 -l· 0.02
0.36 + 0.05
0.13 + 0.01
0.13 + 0.02
Recovery
1.99 + 0.16
2.29 + 0.20
0.15 + 0.02
0.30 + 0.03
0.11 + 0.01
0.21 + 0.04
Tab. 2. The effect of the cold pressor test on blood pressure (mm Hg) and heart rate (min"1) in 23 patients with Raynantfs
phenomenon and in 19 healthy controls.
Heart rate
Arterial pressure
systolic
diastolic
Patients
Baseline
71 ±2*
115 + 2*
77 ±2*
Cold
pressure
test
76 ±2*
135 H- 4*
91 ± 3*
Recovery
71 ±2
114 + 2
7 8 + 2
Controls
Baseline
73 + 2
120 + 3*
83 + 2*
Cold
pressure
test
78 + 2**
140 ±>
92 + 2*
.
Recovery
72 ±2
120 + 3
81 ±2
* p < 0.001
** p < 0.002
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Discussion
Although indirect estimation of sympathetic function
at rest by venous plasma catecholamines is contro-
versial (9, 10), examination of circulating catechol-
amines during various Stimuli is still widely used to
detect possible differences in sympathetic activity be-
tween normals and patients (11).
In this study we showed that:
1) during the cold test patients' plasma norepinephrine
was within the normal ränge;
2) patients' plasma epinephrine levels were low at rest,
but significantly increased during the cold pressor test;
and
3) 30 min after the cold test, plasma dopamine sig-
nificantly increased in controls but remained un-
changed in patients.
The normal basal norepinephrine concentration and
i the normal increase of norepinephrine during the cold
! pressor test would indicate a normal sympathetic re-
sponse to cold Stimulation in patients with Raynaud's
phenomenon (12, 13). Rather interestingly we found
that epinephrine was particularly low in patients with
Raynaud's phenomenon. Few and controversial data
on plasma epinephrine in this disease have been pub-
lished (14, 15) and the physiological significance of
plasma epinephrine is still not known even for healthy
individuals (16). Since virtually all plasma epinephrine
is derived from adrenal medullary tissue (17), and
since adrenalectomized hunians have low resting cir-
culating epinephrine which increases after Stimulation
(18), with normal haemodynamic and plasma nor-
epinephrine responses to the cold test (19), an im-
pairment of adrenomedullary epinephrine secretion in
Raynaud's phenomenon cannot be ruled out. How-
ever, since adrenalectomized persons are not at in-
creased risk of vasospastic attacks, the low plasma
epinephrine levels of oür patients may be seen äs an
epiphenomenon. Since acetylcholine relased from
parasympathetic nerves may pläy a part in regulatipn
of the adrenal release of epinephrine (20) and since
parasympathetic dysfunction in Raynaud's phenome-
non has been reported (21), the low plasma epineph-
rine in our patients might be related to parasympath-
etic damage. Low values of epinephrine might be
associated also with depression (22). On the other
band, it is not possible to rule out that low circulating
epinephrine might compensate for some abnormality
of sympatho-adrenal receptors (23 — 25). The in-
creased epinephrine found in patients during the cold
test could indicate that this manoeuvre was more
stressful to those subjects who knew in advance that
cooling would be particularly stressing. An increase
of epinephrine is considered in fact to be the most
sensitive neuroendocrine response to stress (26). The
response of plasma dopamine to cold Stimulation is
particularly intriguing. The mechanism for the Vari-
ation of dopamine levels is unknown, mainly because
the source of circulating dopamine has not yet been
clearly established (27, 28). While dopamine changes
observed in controls during the cold test are in accord
with those in previous studies (29), there is little in-
formation on measurement in the recovery phase fol-
lowing sympathetic Stimulation, although dopamine
levels have been found to be unchanged after bicycle
exercise and cross-country march (30). The different
behaviour of dopamine vs norepinephrine and epi-
nephrine 30 min after the cold test observed in our
controls suggests that circulating dopamine has a role
of its own and does not represent a mere reserve for
circulating norepinephrine and epinephrine (27); in
accord with this, we saw no correlation between the
levels of dopamine and those of norepinephrine and
epinephrine. Since dopamine has been hypothesized
to be involved in vasodilatation (31, 32), it is tempting
to speculate that circulating dopamine might be a
physiological mediator for post-ischaemic vasodila-
tation. However, because of the variable dopamine
increase in controls during the recovery phase, the
physiological importance of the small but significantly
different dopamine behaviour between patients and
controls, which we found in the recovery phase, is
still unclear.
In conclusion, the normal plasma norepinephrine pat-
tern observed in patients would indicate a normal
sympathetic response to cold Stimulation in Raynauds
phenomenon, while the abnormal plasma epinephrine
might be consistent with higher stress rating in pa-
tients. The changes in circulating dopamine might
indicate that dopamine plays a role in post-ischaemic
vasodilatation, a role which would be impaired in
patients with Raynaud's phenomenon. Further evi-
dence is necessary to evaluate the physiological role
of dopamine in the post-ischaemic vasodilatation.
This work is supported in part by "Gruppo Nazionale Cardio-
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